000 | 01808 a2200529 4500 | ||
---|---|---|---|
005 | 20250513091744.0 | ||
264 | 0 | _c19960808 | |
008 | 199608s 0 0 eng d | ||
022 | _a0022-4804 | ||
024 | 7 |
_a10.1006/jsre.1996.0216 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFriese, R S | |
245 | 0 | 0 |
_aNO prevents neutrophil-mediated pulmonary vasomotor dysfunction in acute lung injury. _h[electronic resource] |
260 |
_bThe Journal of surgical research _cJun 1996 |
||
300 |
_a23-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAcetylcholine _xpharmacology |
650 | 0 | 4 | _aAdministration, Inhalation |
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCyclic GMP _xmetabolism |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 |
_aEndothelium, Vascular _xdrug effects |
650 | 0 | 4 |
_aEndotoxins _xtoxicity |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMuscle, Smooth, Vascular _xdrug effects |
650 | 0 | 4 |
_aNeutrophils _xdrug effects |
650 | 0 | 4 |
_aNitric Oxide _xadministration & dosage |
650 | 0 | 4 |
_aNitroprusside _xpharmacology |
650 | 0 | 4 |
_aPeroxidase _xmetabolism |
650 | 0 | 4 |
_aPulmonary Artery _xdrug effects |
650 | 0 | 4 |
_aPulmonary Circulation _xdrug effects |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 | _aSalmonella typhimurium |
650 | 0 | 4 | _aVasoconstriction |
650 | 0 | 4 | _aVasodilation |
700 | 1 | _aFullerton, D A | |
700 | 1 | _aMcIntyre, R C | |
700 | 1 | _aRehring, T F | |
700 | 1 | _aAgrafojo, J | |
700 | 1 | _aBanerjee, A | |
700 | 1 | _aHarken, A H | |
773 | 0 |
_tThe Journal of surgical research _gvol. 63 _gno. 1 _gp. 23-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1006/jsre.1996.0216 _zAvailable from publisher's website |
999 |
_c8660032 _d8660032 |